在临床测试的复合西尼罗病毒包膜蛋白疫苗的In silico后期分析

Jesús Reiné1, Rosaria Tinnirello2, Alberto Cagigi3

  • 1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Centro de Estudios de Salud, Universidad del Valle de Guatemala, Guatemala City, Guatemala.

概括

计算疫苗学工具支持对西尼罗河病毒 (WNV) 包膜 (Env) 蛋白WN80E的评估. 一种变体,WNM80E,显示了可比的结构,并改善了预测的稳定性和免疫性.